Literature DB >> 17636307

Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005.

Alisha Ruth Davies1, Liam Smeeth, Emily Marjatta Dorothea Grundy.   

Abstract

AIMS: To assess how trends in the incidence of coronary heart disease (CHD) and mortality rates among people with CHD have affected the prevalence of CHD in the UK. METHODS AND
RESULTS: A time trend analysis using computerized general practice clinical records of people aged 35 years and over was performed. From 1996 to 2005, age-standardized incidence of CHD decreased by 2.2% in men and 2.3% in women per year (average percentage change). Age-standardized all-cause mortality among those with CHD decreased by 4.5% in men and 3.4% in women per year (average percentage change). Age-standardized prevalence increased by 1.3% in men and 1.7% in women per year (average percentage change). Although the decline in incidence had some impact on limiting the increase in prevalence, its effect was offset by the increase in prevalence occurring as a result of improved survival among people with CHD.
CONCLUSION: The results suggest that increasing prevalence is largely due to decreasing mortality among people with CHD. Further increases in prevalence are likely even if the incidence of CHD continues to fall.

Entities:  

Mesh:

Year:  2007        PMID: 17636307     DOI: 10.1093/eurheartj/ehm272

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  26 in total

Review 1.  Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population.

Authors:  Ginés Sanz; Valentin Fuster
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-23

2.  The CVD paradox: mortality vs prevalence.

Authors:  Valentin Fuster; Bryony M Mearns
Journal:  Nat Rev Cardiol       Date:  2009-11       Impact factor: 32.419

3.  Patients with cardiac disease: Changes observed through last decade in out-patient clinics.

Authors:  Alberto Cordero; Vicente Bertomeu-Martínez; Pilar Mazón; Lorenzo Fácila; Juan Cosín; Vicente Bertomeu-González; Moisés Rodriguez; Eva Andrés; Enrique Galve; Iñaki Lekuona; Jose R González-Juanatey
Journal:  World J Cardiol       Date:  2013-08-26

4.  Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study.

Authors:  John H Page; Jing Ma; Michael Pollak; Joann E Manson; Susan E Hankinson
Journal:  Clin Chem       Date:  2008-08-14       Impact factor: 8.327

5.  Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study.

Authors:  Kate Smolina; Frances L Wright; Mike Rayner; Michael J Goldacre
Journal:  Eur J Public Health       Date:  2012-01-11       Impact factor: 3.367

6.  Levels and trends in cardiovascular risk factors and drug treatment in 4837 elderly Dutch myocardial infarction patients between 2002 and 2006.

Authors:  S S Soedamah-Muthu; J M Geleijnse; E J Giltay; J de Goede; L M Oude Griep; E Waterham; A M Teitsma-Jansen; B J M Mulder; M-J de Boer; J W Deckers; P L Zock; D Kromhout
Journal:  Neth Heart J       Date:  2012-02-08       Impact factor: 2.380

7.  Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study.

Authors:  Kate Smolina; F Lucy Wright; Mike Rayner; Michael J Goldacre
Journal:  BMJ       Date:  2012-01-25

8.  The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings.

Authors:  Viswanathan Mohan; Yackoob K Seedat; Rajendra Pradeepa
Journal:  Int J Hypertens       Date:  2013-03-14       Impact factor: 2.420

9.  Coding, recording and incidence of different forms of coronary heart disease in primary care.

Authors:  Nawaraj Bhattarai; Judith Charlton; Caroline Rudisill; Martin C Gulliford
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

10.  Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study.

Authors:  Rosalind Raine; Wun Wong; Gareth Ambler; Sarah Hardoon; Irene Petersen; Richard Morris; Mel Bartley; David Blane
Journal:  BMJ       Date:  2009-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.